These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26311355)

  • 1. β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.
    Ando S; Shibahara J; Hayashi A; Fukayama M
    Virchows Arch; 2015 Nov; 467(5):535-42. PubMed ID: 26311355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
    Yeh MM; Liu Y; Torbenson M
    Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.
    Shibahara J; Ando S; Sakamoto Y; Kokudo N; Fukayama M
    Histopathology; 2014 Jun; 64(7):951-62. PubMed ID: 24898917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.
    Lee JS; Yoo JE; Kim H; Rhee H; Koh MJ; Nahm JH; Choi JS; Lee KH; Park YN
    PLoS One; 2017; 12(3):e0171922. PubMed ID: 28273155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
    J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene.
    Cieply B; Zeng G; Proverbs-Singh T; Geller DA; Monga SP
    Hepatology; 2009 Mar; 49(3):821-31. PubMed ID: 19101982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.
    Gougelet A; Sartor C; Senni N; Calderaro J; Fartoux L; Lequoy M; Wendum D; Talbot JN; Prignon A; Chalaye J; Imbeaud S; Zucman-Rossi J; Tordjmann T; Godard C; Bossard P; Rosmorduc O; Amaddeo G; Colnot S
    Gastroenterology; 2019 Sep; 157(3):807-822. PubMed ID: 31194980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steatotic and Steatohepatitic Hepatocellular Carcinomas: Features in a Series With Predominantly Viral Etiology.
    Aykutlu U; Argon A; Orman M; Ulukaya S; Zeytunlu M; Karasu Z; Günşar F; Nart D; Akarca U; Yilmaz F
    Am J Surg Pathol; 2021 Sep; 45(9):1252-1263. PubMed ID: 33826548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications.
    Tao J; Krutsenko Y; Moghe A; Singh S; Poddar M; Bell A; Oertel M; Singhi AD; Geller D; Chen X; Lujambio A; Liu S; Monga SP
    Hepatology; 2021 Aug; 74(2):741-759. PubMed ID: 33529367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic Characteristics.
    Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Sanada J; Koda W; Minami T; Inoue D; Yoshida K; Yamashita T; Yamashita T; Kaneko S; Takamura H; Ohta T; Ikeda H; Nakanuma Y; Kita R; Gabata T
    Radiology; 2015 Jun; 275(3):708-17. PubMed ID: 25668519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
    Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
    J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics of Wnt/β-catenin-deregulated hepatocellular carcinoma.
    Verma A; Bal M; Ramadwar M; Deodhar K; Patil P; Goel M
    Indian J Cancer; 2017; 54(4):634-639. PubMed ID: 30082549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
    Zucman-Rossi J; Benhamouche S; Godard C; Boyault S; Grimber G; Balabaud C; Cunha AS; Bioulac-Sage P; Perret C
    Oncogene; 2007 Feb; 26(5):774-80. PubMed ID: 16964294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.
    Audard V; Grimber G; Elie C; Radenen B; Audebourg A; Letourneur F; Soubrane O; Vacher-Lavenu MC; Perret C; Cavard C; Terris B
    J Pathol; 2007 Jul; 212(3):345-52. PubMed ID: 17487939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1.
    Devereux TR; Stern MC; Flake GP; Yu MC; Zhang ZQ; London SJ; Taylor JA
    Mol Carcinog; 2001 Jun; 31(2):68-73. PubMed ID: 11429783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic and Proteomic Analysis of Steatohepatitic Hepatocellular Carcinoma Reveals Novel Distinct Biologic Features.
    Van Treeck BJ; Mounajjed T; Moreira RK; Orujov M; Allende DS; Bellizzi AM; Lagana SM; Davila JI; Jessen E; Graham RP
    Am J Clin Pathol; 2021 Jan; 155(1):87-96. PubMed ID: 32885245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
    Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
    Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.